Coactin: Full Drug Profile
Coactin - General Information
Amidinopenicillanic acid derivative with broad spectrum antibacterial action. It is poorly absorbed if given orally and is used in urinary infections and typhus.
Pharmacology of Coactin
Coactin is a novel, semisynthetic penicillin effective against many gram-negative bacteria. The antibacterial activity of amdinocillin is derived from its ability to bind specifically and avidly to Penicillin Binding Protein-2 (PBP 2). Coactin is active alone against many gram-negative organisms. Pseudomonas and non-fermenting gram-negative bacteria, however, are usually resistant. Coactin, in combination with many beta-lactams, exhibits marked synergy against many enterobacteriaceae. No such synergy can be demonstrated for gram-positive organisms or pseudomonas species. Coactin is not beta-lactamase stable. Organisms which produce high levels of plasma-mediated beta-lactamase are resistant to the drug. Co-administration of probenecid results in markedly elevated plasma levels of amdinocillin and delays its excretion.
Additional information about Coactin
- Coactin Indication
Used in the treatment of urinary tract infections caused by some strains of E. coli and klebsiella and enterobacter species.
- Mechanism Of Action
- Coactin is a stong and specific antagonist of Penicillin Binding Protein-2 (PBP 2).
- Generic Name
- Amdinocillin
- Synonyms
- Amdinocillin mecillinam
- Drug Category
- Anti-Bacterial Agents; Penicillins; Anti-Infective Agents, Urinary
- Drug Type
- Small Molecule; Approved
- Other Brand Names containing Amdinocillin
- Coactin;
- Absorption
- Poorly absorbed if given orally.
- Half Life
- Approximately 1 hour in patients with normal renal function. Increases to 3 to 6 hours in anephric patients.
- Chemical IUPAC Name
- (2S,5R,6R)-6-(azepan-1-ylmethylideneamino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
- Chemical Formula
- C15H23N3O3S
- Organisms Affected
- Gram-negative Bacteria
